An antagonist of GPR55, blocking LPI-induced activation (EC₅₀ = 1.1 µM); has minimal effect at the GPR35 and CB2, although it acts as a weak antagonist of CB1 (IC₅₀ = 17.7 µM); inhibits LPI-induced phosphorylation of ERK1/2 and blocks receptor-dependent…